Experts mull effect of isotope bill on diagnostic imaging industry

01/24/2013 | Diagnostic Imaging

President Barack Obama recently signed the American Medical Isotope Production Act of 2011, which promotes domestic production of low-enriched uranium-based isotopes, and industry experts are weighing the effect of this on the diagnostic imaging field. Colleen Glynn, senior marketing director for the Nuclear Pharmacy Services Business of Cardinal Health, said the use of LEU is not new, as it has long been the normal practice to use a blend of LEU- and highly enriched uranium-based molybdenum-99. Lynn Phillips of Covidien's pharmaceutical unit Mallinckrodt said the subsidiary can produce LEU-derived technetium-99m generators that comply with CMS criteria, but clients have yet to ask for them.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA